Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 70
Filter
1.
Eur Rev Med Pharmacol Sci ; 28(11): 3787-3795, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38884514

ABSTRACT

OBJECTIVE: Burns are among the most common injuries in children. In burns of more than 20% of the total body surface area, a systemic inflammatory response involving several chemical mediators occurs. Among them, nerve growth factor (NGF) regulates the inflammatory response related to wound healing and promotes keratinocyte proliferation and angiogenesis. The aim of our study was to investigate the physiological response to injury in children with moderate-severe burns, assaying proNGF, mature NGF (mNGF), interleukins (IL)-1ß, and Il-10 serum levels. PATIENTS AND METHODS: This is a prospective observational study, including twelve children hospitalized for moderate-severe burns at the Gemelli Hospital (Rome). Their laboratory features were compared to those of patients with obstructive hydrocephalus who underwent surgery. RESULTS: Our results showed an increase in proNGF and mNGF serum levels. In burn patients, proNGF levels increased before mNGF, and serum concentrations of both were not correlated with burn extension and depth. The most significant levels of mNGF and proNGF were reported in scalds involving the face. Serum IL-1ß and IL-10 peak levels were reached with a time-course pattern similar to proNGF. CONCLUSIONS: Our preliminary results validate the hypothesis that serum levels of proNGF and mNGF may represent inflammatory biomarkers useful for monitoring burn patients and defining new strategies for their treatment.


Subject(s)
Burns , Nerve Growth Factor , Humans , Nerve Growth Factor/blood , Burns/blood , Child , Prospective Studies , Female , Male , Child, Preschool , Interleukins/blood , Interleukin-1beta/blood , Interleukin-10/blood , Infant , Protein Precursors/blood
2.
J Anesth Analg Crit Care ; 1(1): 24, 2021 Dec 14.
Article in English | MEDLINE | ID: mdl-37386530

ABSTRACT

BACKGROUND: Life-threatening streptococcal sepsis nowadays represents an uncommon event in previously healthy infants and children. Critically ill patients suffering from severe streptococcal sepsis complications may present with pre-antibiotic era clinical pictures and require a timely clinical approach to achieve restitutio ad integrum. RESULTS: We report a series of four patient groups affected by an uncommon life-threatening streptococcal sepsis, each of them exhibiting some distinct features. Streptococcus Agalactiae sepsis was associated with cerebral thrombotic/ischaemic lesions, whereas severe cardiogenic shock was prominent in the Streptococcus Viridans group; Streptococcus Faecalis and ß-hemolytic group A Streptococcus patients mostly reported lung complications. CONCLUSIONS: Previous antibiotic treatments should not delay aggressive treatment in the intensive care setting. Early diagnostic suspicion, as well as appropriate and aggressive treatment provided within an intensive care setting are crucial for the clinical outcome.

3.
J Neural Eng ; 17(5): 056031, 2020 10 15.
Article in English | MEDLINE | ID: mdl-33055363

ABSTRACT

OBJECTIVE: Implantable electrodes, such as electrocorticography (ECoG) grids, are used to record brain activity in applications like brain computer interfaces. To improve the spatial sensitivity of ECoG grid recordings, electrode properties need to be better understood. Therefore, the goal of this study is to analyze the importance of including electrodes explicitly in volume conduction calculations. APPROACH: We investigated the influence of ECoG electrode properties on potentials in three geometries with three different electrode models. We performed our simulations with FEMfuns, a volume conduction modeling software toolbox based on the finite element method. MAIN RESULTS: The presence of the electrode alters the potential distribution by an amount that depends on its surface impedance, its distance from the source and the strength of the source. Our modeling results show that when ECoG electrodes are near the sources the potentials in the underlying tissue are more uniform than without electrodes. We show that the recorded potential can change up to a factor of 3, if no extended electrode model is used. In conclusion, when the distance between an electrode and the source is equal to or smaller than the size of the electrode, electrode effects cannot be disregarded. Furthermore, the potential distribution of the tissue under the electrode is affected up to depths equal to the radius of the electrode. SIGNIFICANCE: This paper shows the importance of explicitly including electrode properties in volume conduction models for accurately interpreting ECoG measurements.


Subject(s)
Brain-Computer Interfaces , Electrocorticography , Electrodes , Electrodes, Implanted , Software
4.
Neuroinformatics ; 18(4): 569-580, 2020 10.
Article in English | MEDLINE | ID: mdl-32306231

ABSTRACT

Applications such as brain computer interfaces require recordings of relevant neuronal population activity with high precision, for example, with electrocorticography (ECoG) grids. In order to achieve this, both the placement of the electrode grid on the cortex and the electrode properties, such as the electrode size and material, need to be optimized. For this purpose, it is essential to have a reliable tool that is able to simulate the extracellular potential, i.e., to solve the so-called ECoG forward problem, and to incorporate the properties of the electrodes explicitly in the model. In this study, this need is addressed by introducing the first open-source pipeline, FEMfuns (finite element method for useful neuroscience simulations), that allows neuroscientists to solve the forward problem in a variety of different geometrical domains, including different types of source models and electrode properties, such as resistive and capacitive materials. FEMfuns is based on the finite element method (FEM) implemented in FEniCS and includes the geometry tessellation, several electrode-electrolyte implementations and adaptive refinement options. The Python code of the pipeline is available under the GNU General Public License version 3 at https://github.com/meronvermaas/FEMfuns . We tested our pipeline with several geometries and source configurations such as a dipolar source in a multi-layer sphere model and a five-compartment realistically-shaped head model. Furthermore, we describe the main scripts in the pipeline, illustrating its flexible and versatile use. Provided with a sufficiently fine tessellation, the numerical solution of the forward problem approximates the analytical solution. Furthermore, we show dispersive material and interface effects in line with previous literature. Our results indicate substantial capacitive and dispersive effects due to the electrode-electrolyte interface when using stimulating electrodes. The results demonstrate that the pipeline presented in this paper is an accurate and flexible tool to simulate signals generated on electrode grids by the spatiotemporal electrical activity patterns produced by sources and thereby allows the user to optimize grids for brain computer interfaces including exploration of alternative electrode materials/properties.


Subject(s)
Electrocorticography/methods , Finite Element Analysis , Models, Theoretical , Cerebral Cortex , Electrodes , Humans
5.
Neurocrit Care ; 33(1): 124-131, 2020 08.
Article in English | MEDLINE | ID: mdl-31696410

ABSTRACT

BACKGROUND AND AIMS: Lipid peroxidation represents a marker of secondary brain injury both in traumatic and in non-traumatic conditions-as in major neurosurgical procedures-eventually leading to brain edema amplification and further brain damage. Malondialdehyde (MDA), a lipid peroxidation marker, and ascorbate, a marker of antioxidant status, can represent early indicators of this process within the cerebrospinal fluid (CSF). We hypothesized that changes in cerebral lipid peroxidation can be measured ex vivo following neurosurgery in children. METHODS: Thirty-six children (M:F = 19/17, median age 32.9 months; IQR 17.6-74.6) undergoing neurosurgery for brain tumor removal were admitted to the pediatric intensive care unit (PICU) in the postoperative period with an indwelling intraventricular catheter for intracranial pressure monitoring and CSF drainage. Plasma and CSF samples were obtained for serial measurement of MDA, ascorbate, and cytokines. RESULTS: An early brain-limited increase in lipid peroxidation was measured, with a significant increase from baseline of MDA in CSF (p = 0.007) but not in plasma. In parallel, ascorbate in CSF decreased (p = 0.05). Systemic inflammatory response following brain surgery was evidenced by plasma IL-6/IL-8 increase (p 0.0022 and 0.0106, respectively). No correlation was found between oxidative response and tumor site or histology (according to World Health Organization grading). Similarly, lipid peroxidation was unrelated to the length of surgery (mean 321 ± 73 min), or intraoperative blood loss (mean 20.9 ± 16.8% of preoperative volemia, 44% given hemotransfusions). Median PICU stay was 3.5 days (IQL range 2-5.5 d.), and postoperative ventilation need was 24 h (IQL range 20-61.5 h). The elevation in postoperative MDA in CSF compared with preoperative values correlated significantly with postoperative ventilation need (P = 0.05, r2 0168), while no difference in PICU stay was recorded. CONCLUSIONS: Our results indicate that lipid peroxidation increases consistently following brain surgery, and it is accompanied by a decrease in antioxidant defences; intraventricular catheterization offers a unique chance of oxidative process monitoring. Further studies are needed to evaluate whether monitoring post-neurosurgical oxidative stress in CSF is of prognostic utility.


Subject(s)
Ascorbic Acid/cerebrospinal fluid , Brain Injuries/metabolism , Brain Neoplasms/surgery , Cytokines/cerebrospinal fluid , Lipid Peroxidation , Malondialdehyde/cerebrospinal fluid , Neurosurgical Procedures , Postoperative Complications/metabolism , Antioxidants/metabolism , Ascorbic Acid/blood , Child , Child, Preschool , Cytokines/blood , Drainage , Female , Humans , Infant , Intensive Care Units, Pediatric , Interleukin-6/blood , Interleukin-6/cerebrospinal fluid , Interleukin-8/blood , Interleukin-8/cerebrospinal fluid , Intracranial Pressure , Male , Malondialdehyde/blood , Monitoring, Physiologic , Oxidative Stress , Respiration, Artificial/statistics & numerical data
6.
BMC Pediatr ; 18(1): 282, 2018 08 25.
Article in English | MEDLINE | ID: mdl-30144795

ABSTRACT

BACKGROUND: Noninvasive ventilation (NIV) is increasingly utilized in infants and young children, though associated with high failure rates due to agitation and poor compliance, mostly if patient-ventilator synchronization is required. METHODS: A retrospective cohort study was carried out in an academic pediatric intensive care unit (PICU). Dexmedetomidine (DEX) was infused as unique sedative in 40 consecutive pediatric patients (median age 16 months) previously showing intolerance and agitation during NIV application. RESULTS: During NIV clinical application both COMFORT-B Score and Richmond Agitation-Sedation Scale (RASS) were serially evaluated. Four patients experiencing NIV failure, all due to pulmonary condition worsening, required intubation and invasive ventilation. 36 patients were successfully weaned from NIV under DEX sedation and discharged from PICU. All patients survived until home discharge. CONCLUSION: Our data suggest that DEX may represent an effective sedative agent in infants and children showing agitation during NIV. Early use of DEX in infants/children receiving NIV for acute respiratory failure (ARF) should be considered safe and capable of improving NIV, thus permitting both lung recruitment and patient-ventilator synchronization.


Subject(s)
Dexmedetomidine/therapeutic use , Hypnotics and Sedatives/therapeutic use , Noninvasive Ventilation , Respiratory Insufficiency/therapy , Child, Preschool , Dexmedetomidine/adverse effects , Female , Humans , Hypnotics and Sedatives/adverse effects , Infant , Intensive Care Units, Pediatric , Male , Oxygen/blood , Patient Comfort , Patient Compliance , Retrospective Studies
11.
Paediatr Int Child Health ; 36(4): 282-287, 2016 Nov.
Article in English | MEDLINE | ID: mdl-26365297

ABSTRACT

Streptococcus pneumoniae sepsis has high morbidity, particularly if complicated by renal injury. Four patients with S. pneumonia invasive infections complicated by renal disorders are presented. The first case was an 18-month-old girl with pneumococcal empyema complicated by haemolytic uraemic (HUS) syndrome. She made a full recovery after mechanical ventilation, inotropic support and haemodiafiltration. The second was a 4-year-old boy who presented with acute post-infectious glomerulonephritis associated with bilateral pneumococcal pneumonia. He too made a complete recovery. The third was a newborn girl with pneumococcal meningitis complicated by acute respiratory distress syndrome and acute renal failure. The fourth patient was an 8-month-old boy with pneumococcal pneumonia and meningitis complicated by HUS and with fulminant thrombotic thrombocytopenic purpura. Despite full support including mechanical ventilation and haemodiafiltration, he died 4 days after admission. On follow-up, all three survivors recovered completely from their pulmonary symptoms and had normal renal function and cardio-circulatory status in the mid-term.


Subject(s)
Kidney Diseases/microbiology , Kidney Diseases/pathology , Pneumococcal Infections/microbiology , Pneumococcal Infections/pathology , Sepsis/complications , Sepsis/microbiology , Streptococcus pneumoniae/isolation & purification , Child, Preschool , Critical Illness , Fatal Outcome , Female , Humans , Infant , Infant, Newborn , Male , Treatment Outcome
13.
Eur Rev Med Pharmacol Sci ; 18(4): 485-92, 2014.
Article in English | MEDLINE | ID: mdl-24610614

ABSTRACT

In Italy viper bites represent an uncommon event, though envenomation can cause severe complications, more in children than adults, because of dose/body size ratio. We present a case series within a selected population: 10 Italian cases (from Rome surroundings) of viperbites requiring PICU admission, over a 5-year interval. Five children showed a systemic involvement, whereas the remaining patients showed a damage. All were managed and closely monitored in an ICU setting. Relevant clinical findings and therapeutic approach, ICU course and complications have been recorded. Age range was 3-15 years with mean age of 6,9 (SD±4,58) years; 2 patients needed respiratory support beyond oxygen supplementation. Most patients underwent fluid loading, while hemodynamic support was given to4/10. Median PICU stay was 60 hours (IQR=24.0-75.5). No mortality was reported. Indications and precautions for administration of antivenom in the last years have been reviewed: early treatment seems to reduce mortality/morbidity, though representing a threat for children. Current recommendations for the treatment of viper envenomation have been described, based on a literature's review and the application of these knowledges to clinical reality of our PICUs. Therefore, paediatric patients with systemic or rapidly evolving symptoms should be monitored carefully for the development of bite-related complications in an ICU setting mostly in younger children.


Subject(s)
Antivenins/therapeutic use , Critical Care/methods , Intensive Care Units, Pediatric , Snake Bites/therapy , Viperidae , Adolescent , Age Factors , Animals , Cardiovascular Agents/therapeutic use , Child , Child, Preschool , Combined Modality Therapy , Critical Care/standards , Evidence-Based Medicine , Female , Fluid Therapy , Hemodynamics , Humans , Intensive Care Units, Pediatric/standards , Male , Oxygen Inhalation Therapy , Practice Guidelines as Topic , Predictive Value of Tests , Respiration, Artificial , Rome , Snake Bites/complications , Snake Bites/diagnosis , Snake Bites/physiopathology , Time Factors , Treatment Outcome
15.
Int J Hematol ; 96(3): 390-4, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22869453

ABSTRACT

Transfusion-related acute lung injury (TRALI) is a frequently under-diagnosed, although potentially fatal, condition that represents a leading cause of transfusion-related morbidity and mortality even in pediatric patients. Its main clinical features are characterized by rapidly evolving respiratory distress, hypoxia, pulmonary edema, and bilateral infiltrates on chest radiograph during or within 6 h of transfusion. We present a case of severe TRALI associated with myocardial stunning that occurred in a 14-year-old girl, and review the existing literature of pediatric TRALI. Our report suggests a potential role for NIV in the management of TRALI as the best profile both in terms of safety and effectiveness for hematologic patients.


Subject(s)
Acute Lung Injury/etiology , Acute Lung Injury/therapy , Myocardial Stunning/etiology , Myocardial Stunning/therapy , Noninvasive Ventilation , Transfusion Reaction , Acute Lung Injury/diagnostic imaging , Adolescent , Female , Humans , Myocardial Stunning/diagnostic imaging , Radiography
17.
J Matern Fetal Neonatal Med ; 25(9): 1627-30, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22185327

ABSTRACT

BACKGROUND: Congenital chylothorax (CC) is a rare and potentially life-threatening condition. Over 50% occurs at birth and is considered as the most common cause of neonatal thoracic fluid collection. OBJECTIVES: To analyse the main clinical and respiratory features of a contemporary group of CC infants. METHODS: Databases for CC diagnosed between 2004 and 2009 were reviewed: 10 consecutive cases were retrieved and analysed. RESULTS: Median gestational age of CC patients was 31.8 weeks. Most patients were diagnosed prenatally (7/10 pts, median GA at diagnosis 28 weeks). Severe respiratory distress at birth required respiratory support: 7/10 newborns received high-frequency oscillatory ventilation (HFOV) electively. Large effusions and/or early-onset pneumothorax did not influence the outcome, while prematurity did not impact significantly on mortality (death rate <33 weeks: 28%). The overall ICU survival rate was 70%. CONCLUSION: CC still carries a significant risk of perinatal mortality. Continuous advances in foetal/neonatal medicine and intensive care have considerably improved the prognosis in the last decades, mostly in critically ill infants. HFOV improves lung opening and volume maintenance, possibly shortening the lymph flow over time. It can play a fundamental role both to prevent hypoxic and chronic lung damage and to improve lung recruitment in neonates born with CC.


Subject(s)
Chylothorax/congenital , Infant, Premature, Diseases/therapy , Respiration, Artificial/methods , Respiratory Distress Syndrome, Newborn/therapy , Chylothorax/complications , Chylothorax/diagnosis , Chylothorax/epidemiology , Chylothorax/therapy , Cohort Studies , Female , Gestational Age , High-Frequency Ventilation/statistics & numerical data , Humans , Infant, Newborn , Infant, Premature , Infant, Premature, Diseases/diagnosis , Infant, Premature, Diseases/epidemiology , Intermittent Positive-Pressure Ventilation/statistics & numerical data , Male , Prognosis , Respiration, Artificial/statistics & numerical data , Respiratory Distress Syndrome, Newborn/diagnosis , Respiratory Distress Syndrome, Newborn/epidemiology , Respiratory Distress Syndrome, Newborn/etiology , Retrospective Studies , Treatment Outcome
19.
Eur Respir J ; 37(3): 678-89, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21357925

ABSTRACT

Administration of drugs directly into the respiratory tree first was proposed a long time ago. Surfactant is the paradigmatic example of such therapies. Many other drugs have been used in the same way and further compounds are under investigation for this aim. In the last two decades, despite the wide number of drugs available for direct lung administration in critical care patients, few controlled data exist regarding their use in neonates and infants. This review will focus on drugs clinically available in a critical care setting for neonates and infants, including bronchodilators, pulmonary vasodilators, anti-inflammatory agents, mucolytics, resuscitative anti-infective agents, surfactants and other drugs. We provide an evidence-based comprehensive review of drugs available for intratracheal administration in paediatric and neonatal critical care and we examine possible advantages and risks for each proposed indication.


Subject(s)
Respiratory System/pathology , Administration, Inhalation , Adrenergic beta-2 Receptor Agonists/metabolism , Bronchodilator Agents/pharmacology , Child , Cholinergic Antagonists/metabolism , Critical Care/methods , Epinephrine/metabolism , Evidence-Based Medicine/methods , Gases , Humans , Intensive Care, Neonatal/methods , Nitric Oxide/metabolism , Prostaglandins I/metabolism , S-Nitrosothiols/chemistry , Steroids/chemistry , Surface-Active Agents/pharmacology
20.
J Matern Fetal Neonatal Med ; 24(8): 1060-4, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21250913

ABSTRACT

OBJECTIVE: The primary outcome measure of this study was the ability of rHuEPOα therapy to reduce transfusion needs, whereas secondary outcome measures were NICU-LOS and ventilation need. METHODS: All babies with BW <1250 g and GA <30 were eligible. Thirty premature neonates were enrolled in the study (10 treated, 20 controls). rHuEPOα was administered as 300 IU/kg/dose 3 times/week subcutaneously. Iron, folic acid and Vitamin E supplementation were administered in both groups. Hematologic variables and blood sampling were recorded during the study. RESULTS: In rHuEPO group, only four (40%) premature infants required a transfusion, averaging 0.4 ±â€Š0.52 transfusions/pts. A total of 23 transfusions were administered to controls; 11 (55%) infants received one transfusion at least, 55% required multiple transfusions. The average number of transfusions/pts was statistically different (1.15  ±â€Š 1.46 vs. 0.4 ±â€Š0.52; p = 0.02), as the cumulative number of transfused patients (55% vs. 40%; p<0.001). NICU stay was not statistically different, whereas ventilation-free days were increased in EPO group (p<0.05). CONCLUSIONS: R-Hu-EPO treatment in first post-natal weeks markedly enhanced erythropoiesis in severely premature infants compared with matched controls, with a significant impact on transfusion needs. EPO group experienced also a reduction of ventilation time and, possibly, a decreased occurrence of clinical BPD.


Subject(s)
Anemia/drug therapy , Blood Transfusion/statistics & numerical data , Erythropoietin/therapeutic use , Hematinics/therapeutic use , Infant, Premature, Diseases/drug therapy , Respiration, Artificial/statistics & numerical data , Anemia/blood , Anemia/therapy , Case-Control Studies , Combined Modality Therapy , Drug Administration Schedule , Erythropoietin/administration & dosage , Folic Acid/administration & dosage , Folic Acid/therapeutic use , Hematinics/administration & dosage , Humans , Infant, Newborn , Infant, Premature , Infant, Premature, Diseases/blood , Infant, Premature, Diseases/therapy , Infant, Very Low Birth Weight , Intensive Care Units, Neonatal , Iron/administration & dosage , Iron/therapeutic use , Length of Stay/statistics & numerical data , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...